Industry Research Reports
Home > Reports > Service & Software > Global Epigenetics Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Epigenetics Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 133 Pages
Report ld: 4905239
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Epigenetics Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Academic and Research Institutes accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Epigenetics Services leading manufacturers including Bio-Rad, lllumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore, Abcam, New England Biolabs+, etc., dominate supply; the top five capture approximately % of global revenue, with Bio-Rad leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Epigenetics Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Bio-Rad
- lllumina
- QIAGEN
- Thermo Fisher
- Active Motif
- Diagenode
- Agilent
- Merck Millipore
- Abcam
- New England Biolabs+
- PerkinEImer
- Zymo Research
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DNA Methylation
- Histone Modification
- Others
Segment by Application
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization (CRO)
CHAPTER OUTLINE
Chapter 1: Defines the Epigenetics Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Epigenetics Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Epigenetics Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DNA Methylation
1.2.3 Histone Modification
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Epigenetics Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organization (CRO)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Epigenetics Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Epigenetics Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Epigenetics Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Epigenetics Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 DNA Methylation Market Size by Players
3.3.2 Histone Modification Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Epigenetics Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Epigenetics Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Epigenetics Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Epigenetics Services Market Size by Type (2020-2031)
6.4 North America Epigenetics Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Epigenetics Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Epigenetics Services Market Size by Type (2020-2031)
7.4 Europe Epigenetics Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Epigenetics Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Epigenetics Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Epigenetics Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Epigenetics Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Epigenetics Services Market Size by Type (2020-2031)
9.4 Central and South America Epigenetics Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Epigenetics Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Epigenetics Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Epigenetics Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Epigenetics Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bio-Rad
11.1.1 Bio-Rad Corporation Information
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Epigenetics Services Product Features and Attributes
11.1.4 Bio-Rad Epigenetics Services Revenue and Gross Margin (2020-2025)
11.1.5 Bio-Rad Epigenetics Services Revenue by Product in 2024
11.1.6 Bio-Rad Epigenetics Services Revenue by Application in 2024
11.1.7 Bio-Rad Epigenetics Services Revenue by Geographic Area in 2024
11.1.8 Bio-Rad Epigenetics Services SWOT Analysis
11.1.9 Bio-Rad Recent Developments
11.2 lllumina
11.2.1 lllumina Corporation Information
11.2.2 lllumina Business Overview
11.2.3 lllumina Epigenetics Services Product Features and Attributes
11.2.4 lllumina Epigenetics Services Revenue and Gross Margin (2020-2025)
11.2.5 lllumina Epigenetics Services Revenue by Product in 2024
11.2.6 lllumina Epigenetics Services Revenue by Application in 2024
11.2.7 lllumina Epigenetics Services Revenue by Geographic Area in 2024
11.2.8 lllumina Epigenetics Services SWOT Analysis
11.2.9 lllumina Recent Developments
11.3 QIAGEN
11.3.1 QIAGEN Corporation Information
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Epigenetics Services Product Features and Attributes
11.3.4 QIAGEN Epigenetics Services Revenue and Gross Margin (2020-2025)
11.3.5 QIAGEN Epigenetics Services Revenue by Product in 2024
11.3.6 QIAGEN Epigenetics Services Revenue by Application in 2024
11.3.7 QIAGEN Epigenetics Services Revenue by Geographic Area in 2024
11.3.8 QIAGEN Epigenetics Services SWOT Analysis
11.3.9 QIAGEN Recent Developments
11.4 Thermo Fisher
11.4.1 Thermo Fisher Corporation Information
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Epigenetics Services Product Features and Attributes
11.4.4 Thermo Fisher Epigenetics Services Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Epigenetics Services Revenue by Product in 2024
11.4.6 Thermo Fisher Epigenetics Services Revenue by Application in 2024
11.4.7 Thermo Fisher Epigenetics Services Revenue by Geographic Area in 2024
11.4.8 Thermo Fisher Epigenetics Services SWOT Analysis
11.4.9 Thermo Fisher Recent Developments
11.5 Active Motif
11.5.1 Active Motif Corporation Information
11.5.2 Active Motif Business Overview
11.5.3 Active Motif Epigenetics Services Product Features and Attributes
11.5.4 Active Motif Epigenetics Services Revenue and Gross Margin (2020-2025)
11.5.5 Active Motif Epigenetics Services Revenue by Product in 2024
11.5.6 Active Motif Epigenetics Services Revenue by Application in 2024
11.5.7 Active Motif Epigenetics Services Revenue by Geographic Area in 2024
11.5.8 Active Motif Epigenetics Services SWOT Analysis
11.5.9 Active Motif Recent Developments
11.6 Diagenode
11.6.1 Diagenode Corporation Information
11.6.2 Diagenode Business Overview
11.6.3 Diagenode Epigenetics Services Product Features and Attributes
11.6.4 Diagenode Epigenetics Services Revenue and Gross Margin (2020-2025)
11.6.5 Diagenode Recent Developments
11.7 Agilent
11.7.1 Agilent Corporation Information
11.7.2 Agilent Business Overview
11.7.3 Agilent Epigenetics Services Product Features and Attributes
11.7.4 Agilent Epigenetics Services Revenue and Gross Margin (2020-2025)
11.7.5 Agilent Recent Developments
11.8 Merck Millipore
11.8.1 Merck Millipore Corporation Information
11.8.2 Merck Millipore Business Overview
11.8.3 Merck Millipore Epigenetics Services Product Features and Attributes
11.8.4 Merck Millipore Epigenetics Services Revenue and Gross Margin (2020-2025)
11.8.5 Merck Millipore Recent Developments
11.9 Abcam
11.9.1 Abcam Corporation Information
11.9.2 Abcam Business Overview
11.9.3 Abcam Epigenetics Services Product Features and Attributes
11.9.4 Abcam Epigenetics Services Revenue and Gross Margin (2020-2025)
11.9.5 Abcam Recent Developments
11.10 New England Biolabs+
11.10.1 New England Biolabs+ Corporation Information
11.10.2 New England Biolabs+ Business Overview
11.10.3 New England Biolabs+ Epigenetics Services Product Features and Attributes
11.10.4 New England Biolabs+ Epigenetics Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 PerkinEImer
11.11.1 PerkinEImer Corporation Information
11.11.2 PerkinEImer Business Overview
11.11.3 PerkinEImer Epigenetics Services Product Features and Attributes
11.11.4 PerkinEImer Epigenetics Services Revenue and Gross Margin (2020-2025)
11.11.5 PerkinEImer Recent Developments
11.12 Zymo Research
11.12.1 Zymo Research Corporation Information
11.12.2 Zymo Research Business Overview
11.12.3 Zymo Research Epigenetics Services Product Features and Attributes
11.12.4 Zymo Research Epigenetics Services Revenue and Gross Margin (2020-2025)
11.12.5 Zymo Research Recent Developments
12 Epigenetics ServicesIndustry Chain Analysis
12.1 Epigenetics Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Epigenetics Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Epigenetics Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Epigenetics Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Epigenetics Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Epigenetics Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Epigenetics Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Epigenetics Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Epigenetics Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Epigenetics Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Epigenetics Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Services as of 2024)
Table 11. Global Epigenetics Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Epigenetics Services Companies Headquarters
Table 13. Global Epigenetics Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Epigenetics Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Epigenetics Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Epigenetics Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Epigenetics Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Epigenetics Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Epigenetics Services Growth Accelerators and Market Barriers
Table 25. North America Epigenetics Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Epigenetics Services Growth Accelerators and Market Barriers
Table 27. Europe Epigenetics Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Epigenetics Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Epigenetics Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Epigenetics Services Investment Opportunities and Key Challenges
Table 31. Central and South America Epigenetics Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Epigenetics Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Epigenetics Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Bio-Rad Corporation Information
Table 35. Bio-Rad Description and Major Businesses
Table 36. Bio-Rad Product Features and Attributes
Table 37. Bio-Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Bio-Rad Revenue Proportion by Product in 2024
Table 39. Bio-Rad Revenue Proportion by Application in 2024
Table 40. Bio-Rad Revenue Proportion by Geographic Area in 2024
Table 41. Bio-Rad Epigenetics Services SWOT Analysis
Table 42. Bio-Rad Recent Developments
Table 43. lllumina Corporation Information
Table 44. lllumina Description and Major Businesses
Table 45. lllumina Product Features and Attributes
Table 46. lllumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. lllumina Revenue Proportion by Product in 2024
Table 48. lllumina Revenue Proportion by Application in 2024
Table 49. lllumina Revenue Proportion by Geographic Area in 2024
Table 50. lllumina Epigenetics Services SWOT Analysis
Table 51. lllumina Recent Developments
Table 52. QIAGEN Corporation Information
Table 53. QIAGEN Description and Major Businesses
Table 54. QIAGEN Product Features and Attributes
Table 55. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. QIAGEN Revenue Proportion by Product in 2024
Table 57. QIAGEN Revenue Proportion by Application in 2024
Table 58. QIAGEN Revenue Proportion by Geographic Area in 2024
Table 59. QIAGEN Epigenetics Services SWOT Analysis
Table 60. QIAGEN Recent Developments
Table 61. Thermo Fisher Corporation Information
Table 62. Thermo Fisher Description and Major Businesses
Table 63. Thermo Fisher Product Features and Attributes
Table 64. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Thermo Fisher Revenue Proportion by Product in 2024
Table 66. Thermo Fisher Revenue Proportion by Application in 2024
Table 67. Thermo Fisher Revenue Proportion by Geographic Area in 2024
Table 68. Thermo Fisher Epigenetics Services SWOT Analysis
Table 69. Thermo Fisher Recent Developments
Table 70. Active Motif Corporation Information
Table 71. Active Motif Description and Major Businesses
Table 72. Active Motif Product Features and Attributes
Table 73. Active Motif Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Active Motif Revenue Proportion by Product in 2024
Table 75. Active Motif Revenue Proportion by Application in 2024
Table 76. Active Motif Revenue Proportion by Geographic Area in 2024
Table 77. Active Motif Epigenetics Services SWOT Analysis
Table 78. Active Motif Recent Developments
Table 79. Diagenode Corporation Information
Table 80. Diagenode Description and Major Businesses
Table 81. Diagenode Product Features and Attributes
Table 82. Diagenode Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Diagenode Recent Developments
Table 84. Agilent Corporation Information
Table 85. Agilent Description and Major Businesses
Table 86. Agilent Product Features and Attributes
Table 87. Agilent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Agilent Recent Developments
Table 89. Merck Millipore Corporation Information
Table 90. Merck Millipore Description and Major Businesses
Table 91. Merck Millipore Product Features and Attributes
Table 92. Merck Millipore Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Merck Millipore Recent Developments
Table 94. Abcam Corporation Information
Table 95. Abcam Description and Major Businesses
Table 96. Abcam Product Features and Attributes
Table 97. Abcam Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Abcam Recent Developments
Table 99. New England Biolabs+ Corporation Information
Table 100. New England Biolabs+ Description and Major Businesses
Table 101. New England Biolabs+ Product Features and Attributes
Table 102. New England Biolabs+ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. New England Biolabs+ Recent Developments
Table 104. PerkinEImer Corporation Information
Table 105. PerkinEImer Description and Major Businesses
Table 106. PerkinEImer Product Features and Attributes
Table 107. PerkinEImer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. PerkinEImer Recent Developments
Table 109. Zymo Research Corporation Information
Table 110. Zymo Research Description and Major Businesses
Table 111. Zymo Research Product Features and Attributes
Table 112. Zymo Research Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Zymo Research Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Epigenetics Services Product Picture
Figure 2. Global Epigenetics Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DNA Methylation Product Picture
Figure 4. Histone Modification Product Picture
Figure 5. Others Product Picture
Figure 6. Global Epigenetics Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Academic and Research Institutes
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Contract Research Organization (CRO)
Figure 10. Epigenetics Services Report Years Considered
Figure 11. Global Epigenetics Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 13. Global Epigenetics Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Epigenetics Services Revenue Market Share by Region (2020-2031)
Figure 15. Global Epigenetics Services Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. DNA Methylation Revenue Market Share by Player in 2024
Figure 18. Histone Modification Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Epigenetics Services Revenue Market Share by Type (2020-2031)
Figure 21. Global Epigenetics Services Revenue Market Share by Application (2020-2031)
Figure 22. North America Epigenetics Services Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Epigenetics Services Revenue (US$ Million) in 2024
Figure 24. North America Epigenetics Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Epigenetics Services Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Epigenetics Services Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Epigenetics Services Revenue (US$ Million) in 2024
Figure 31. Europe Epigenetics Services Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Epigenetics Services Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 34. France Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Epigenetics Services Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Epigenetics Services Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Epigenetics Services Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Epigenetics Services Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 46. India Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Epigenetics Services Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Epigenetics Services Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Epigenetics Services Revenue (US$ Million) in 2024
Figure 54. Central and South America Epigenetics Services Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Epigenetics Services Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Epigenetics Services Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Epigenetics Services Revenue (US$ Million) in 2024
Figure 60. South America Epigenetics Services Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Epigenetics Services Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Epigenetics Services Revenue (2020-2025) & (US$ Million)
Figure 66. Epigenetics Services Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Epigenetics Services market?
The top companies in the global Epigenetics Services market are Bio-Rad、lllumina、QIAGEN.
Related Reports
Global Epigenetics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Epigenetics Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 137
USD 4900.00
(Single User License)
Global Epigenetics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Epigenetics Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 94
USD 4250.00
(Single User License)
Epigenetics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Epigenetics Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 106
USD 3950.00
(Single User License)
Global Epigenetics Services Market Research Report 2026
The global Epigenetics Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 114
USD 2900.00
(Single User License)
Global Epigenetics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Epigenetics Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
Epigenetics Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Epigenetics Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 111
USD 3950.00
(Single User License)
Global Epigenetics Services Market Research Report 2025
The global market for Epigenetics Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 82
USD 2900.00
(Single User License)
Global Epigenetics Services Market Insights, Forecast to 2030
The global Epigenetics Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-05-09
Pages: 138
USD 4900.00
(Single User License)
Global and United States Epigenetics Services Market Report & Forecast 2024-2030
The global Epigenetics Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-05-09
Pages: 110
USD 4350.00
(Single User License)
Epigenetics Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Epigenetics Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-05-09
Pages: 104
USD 3950.00
(Single User License)
Global Epigenetics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Epigenetics Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 137
USD 4900.00 (Single User License)Global Epigenetics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Epigenetics Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 94
USD 4250.00 (Single User License)Epigenetics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Epigenetics Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 106
USD 3950.00 (Single User License)Global Epigenetics Services Market Research Report 2026
The global Epigenetics Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 114
USD 2900.00 (Single User License)Global Epigenetics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Epigenetics Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
USD 4250.00 (Single User License)Epigenetics Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Epigenetics Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 111
USD 3950.00 (Single User License)Global Epigenetics Services Market Research Report 2025
The global market for Epigenetics Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 82
USD 2900.00 (Single User License)Global Epigenetics Services Market Insights, Forecast to 2030
The global Epigenetics Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-05-09
Pages: 138
USD 4900.00 (Single User License)Global and United States Epigenetics Services Market Report & Forecast 2024-2030
The global Epigenetics Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-05-09
Pages: 110
USD 4350.00 (Single User License)Epigenetics Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Epigenetics Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-05-09
Pages: 104
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now